Intellia Therapeutics, Inc. (NTLA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 21.40 |
| Open | 21.33 |
| Bid | 22.44 x 600 |
| Ask | 22.52 x 100 |
| Day's Range | 21.33 - 23.56 |
| 52 Week Range | 19.37 - 47.48 |
| Volume | |
| Avg. Volume | 1,486,813 |
| Market Cap | 2.17B |
| Beta (5Y Monthly) | 1.80 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
On Intellia's (NTLA) first-quarter 2024 earnings call, investors' focus is likely to be on the progress of its pipeline of genome-editing candidates.
- Zacks
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline
Intellia Therapeutics (NTLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Intellia Therapeutics (NASDAQ:NTLA shareholders incur further losses as stock declines 9.9% this week, taking three-year losses to 65%
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
© 2024 Yahoo. All rights reserved.